| EPC0527 | Changes in resilience among older PLWH in Ukraine during the COVID-19 pandemic and the Russian invasion | E-poster | Epidemiology of COVID-19 |
| EPB0159 | Changes in symptoms of depression and anxiety over time in a cohort of people with HIV initiating HIV care in Cameroon | E-poster | Co-morbidities |
| EPB0168 | Changes in weight after switching from ritonavir-boosted protease inhibitors to dolutegravir/tenofovir alafenamide/emtricitabine: results from a single arm, open-label, phase 3 clinical trial study (SPIRITED) | E-poster | Co-morbidities |
| EPB0226 | Changes in weight and body mass index associated with dolutegravir- and non-dolutegravir-based antiretroviral treatment regimens: a longitudinal analysis | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPA0072 | Characterisation of HIV latency and reactivation in human macrophages | E-poster | Understanding and targeting persistent HIV reservoirs |
| OAC0103 | Characterising HIV incidence among people who inject drugs engaged with harm-reduction programs in four provinces in South Africa | Oral abstract session with live Q&A | Epidemiology of HIV |
| EPB0180 | Characteristics and management of ocular involvement in a large cohort of individuals with Mpox disease | E-poster | Co-morbidities |
| EPE0824 | Characteristics of a target product profile for HIV cure: ex vivo and in vivo gene therapy | E-poster | Implementation science and scale up of treatment |
| EPC0380 | Characteristics of Chinese MSM using HIV pre-exposure prophylaxis (PrEP), a cross-sectional study in 2022 | E-poster | HIV prevention research |
| MOPEC13 | Characteristics of HIV seroconversions in ImPrEP, a large PrEP implementation study in Latin America | Poster exhibition | HIV prevention research |